Estrogen-dependent actions of bone morphogenetic protein-7 on spine fusion in rats

Spine

Volumn 30, Issue 15, 2005, Pages 1706-1711

  Moazzaz, Payam ^a   Gupta, Munish C ^a,b   Gilotra, Mudit M ^a   Gilotra, Mohit N ^a   Maitra, Sukanta ^a   Theerajunyaporn, Thongchai ^a   Chen, James L ^a   Reddi, A Hari ^a   Martin, R Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Estrogen; Insoluble collagen bone matrix; Osteoporosis; Recombinant human bone morphogenetic protein 7; Spinal fusion

Indexed keywords

ESTROGEN; OSTEOGENIC PROTEIN 1; RECOMBINANT OSTEOGENIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MATRIX; CONTROLLED STUDY; DIAGNOSTIC VALUE; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; HISTOPATHOLOGY; INHIBITION KINETICS; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; ESTROGENS; FEMALE; HUMANS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 23244448926     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000172230.01655.55     Document Type: Article

References (34)

1. Sherman S. Preventing and treating osteoporosis: Strategies at the millennium. Ann N Y Acad Sci 2001;949:188-97.
2. Schiessl H, Frost HM, Jee WS. Estrogen and bone-Muscle strength and mass relationships. Bone 1998;22:1-6.
3. Davidge ST, Zhang Y, Stewart KG. Comparison of ovariectomy models for estrogen studies. Am J Physiol Regul Integr Comp Physiol 2001;280: R904-7.
4. Sakakura Y, Shide N, Tsuruga E, et al. Effects of running exercise on the mandible and tibia of ovariectomized rats. J Bone Miner Metab 2001;19: 159-67.
5. World Health Organization. The burden of musculoskeletal conditions at the start of a new millennium. World Health Organization 2003. Available at: http://whqlibdoc.who.int/trs/WHO_TRS_919.pdf. Accessed May 24, 2005.
6. Salamon ML, Althausen PL, Gupta MC, et al. The effects of BMP-7 in a rat posterolateral intertransverse process fusion model. J Spinal Disord 2003;1: 90-95.
7. David SM, Gruber HE, Meyer RA Jr, et al. Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers. Spine 1999;24:1973-9.
8. Hecht BP, Fischgrund JS, Herkowitz HN, et al. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 1999; 24:629-36.
9. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-52.
10. Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A 1981;78:7599-603.
11. Reddi AH, Anderson WA. Collagenous bone matrix-induced endochondral ossification and hemopoiesis. J Cell Biol 1976;69:557-72.
12. Muthukumaran N, Ma S, Reddi AH. Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction. Coll Relat Res 1988;8:433-41.
13. Guizzardi S, Di Silvestre M, Scandroglio R, et al. Implants of heterologous demineralized bone matrix for induction of posterior spinal fusion in rats. Spine 1992;17:701-7.
14. Robertson PA, Wray AC. Natural history of posterior iliac crest bone graft donation for spinal surgery: A prospective analysis of morbidity. Spine 2001; 26:1473-6.
15. Boden SD, Titus L, Hair G, et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein. Spine 1998;23:2486-92.
16. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo award in clinical studies. Spine 2002;27:2662-73.
17. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-81.
18. Vaccaro A, Sharan A, Tuan R, et al. The use of biological materials in spinal fusion. Orthopedics 2001;24:191-7.
19. Kannus P, Niemi S, Palvanen M, et al. Continuously rising problem of Osteoporotic knee fractures in elderly women: Nationwide statistics in Finland in 1970-1999 and predictions until the year 2030. Bone 2001;29:419-23.
20. Boden SD, Schimandle JH, Huttin WC, et al. An experimental lumbar intertransverse process spinal fusion model: Radiographic, histologic, and biomechanical healing characteristics. Spine 1995;20:2633-44.
21. Lenke LG, Bridwell KH, Bullis D, et al. Results of in situ fusion for isthmic spondylolisthesis. J Spinal Disord 1992;5:433-42.
22. Seeman E. Reduced bone formation and increased bone resorption: Rational targets for the treatment of osteoporosis. Osteoporos Int 2003;14:S2-8.
23. Boden S. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 2002;27:S26-31.
24. Schimandle JH, Boden SD. The use of animal models to study spinal fusion. Spine 1994;19:1998-2006.
25. Wang JC, Yoo S, Kanim LE, et al. Gene therapy for spinal fusion. Transformation of marrow cells with an adenoviral vector to produce BMP-2. Paper presented at: Annual Meeting of the Scoliosis Research Society; September 23-24, 1999; San Diego, CA.
26. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20: 1326-37.
27. Sandhu HS, Kanim LE, Kabo JM, et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 1995;20:2669-82.
28. Sandhu HS, Toth JM, Diwan AD, et al. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion. Spine 2002;27:567-75.
29. Akamaru TA, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery or recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003;28:429-34.
30. Kleeman TJ, Ahn UM, Talbot-Kleeman A. Laparoscopic anterior lumbar interbody fusion with rhBMP-2. A prospective study of clinical and radiographic outcomes. Spine 2001;26:2751-6.
31. Vaccaro AR, Anderson DG, Toth CA. Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion. Spine 2002;27:S59-65.
32. Patel TC, Erulkar JS, Grauer JN, et al. Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. Spine 2001;26: 1656-61.
33. Paramore CG, Lauryssen C, Rauzzino MJ, et al. The safety of OP-1 for lumbar fusion with decompression: A canine study. Neurosurgery 1999;44:1151-5.
34. Magin MN, Delling G. Improved lumbar vertebral interbody fusion using rhOP-1: A comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep. Spine 2001;21:469-78.